ATE269695T1 - Pharmazeutische pellets - Google Patents

Pharmazeutische pellets

Info

Publication number
ATE269695T1
ATE269695T1 AT96929522T AT96929522T ATE269695T1 AT E269695 T1 ATE269695 T1 AT E269695T1 AT 96929522 T AT96929522 T AT 96929522T AT 96929522 T AT96929522 T AT 96929522T AT E269695 T1 ATE269695 T1 AT E269695T1
Authority
AT
Austria
Prior art keywords
pharmaceutical pellets
pellets
pharmaceutical
Prior art date
Application number
AT96929522T
Other languages
English (en)
Inventor
Hidero Akiyama
Ohyagi-Machi
Zene Matsumoto
Takashi Ueno
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Application granted granted Critical
Publication of ATE269695T1 publication Critical patent/ATE269695T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96929522T 1995-09-09 1996-09-04 Pharmazeutische pellets ATE269695T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518465.1A GB9518465D0 (en) 1995-09-09 1995-09-09 Pharmaceuticals
PCT/JP1996/002504 WO1997010810A2 (en) 1995-09-09 1996-09-04 Pharmaceutical granules

Publications (1)

Publication Number Publication Date
ATE269695T1 true ATE269695T1 (de) 2004-07-15

Family

ID=10780470

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96929522T ATE269695T1 (de) 1995-09-09 1996-09-04 Pharmazeutische pellets

Country Status (15)

Country Link
US (3) US6242008B1 (de)
EP (1) EP0850048B1 (de)
JP (1) JP2000504309A (de)
AR (1) AR004196A1 (de)
AT (1) ATE269695T1 (de)
AU (1) AU6889396A (de)
CO (1) CO4750645A1 (de)
CY (1) CY2584B2 (de)
DE (1) DE69632787T2 (de)
ES (1) ES2224175T3 (de)
GB (1) GB9518465D0 (de)
PT (1) PT850048E (de)
TW (1) TW426525B (de)
WO (1) WO1997010810A2 (de)
ZA (1) ZA967545B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6858725B1 (en) 1999-11-12 2005-02-22 R.P. Scherer Technologies, Inc. Microcrystalline cellulose cushioning granules
WO2001034684A1 (en) * 1999-11-12 2001-05-17 R.P. Scherer Technologies, Inc. Microcrystalline cellulose cushioning granules
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
US6958908B2 (en) * 2003-05-30 2005-10-25 Hubbell Incorporated Compact enclosure for interchangeable SONET multiplexer cards and methods for using same
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
CN103077978B (zh) 2007-02-16 2016-12-28 纳克公司 太阳能电池结构、光生伏打模块及对应的工艺
WO2010001574A1 (ja) 2008-07-01 2010-01-07 沢井製薬株式会社 タムスロシン塩酸塩を含有する球形微粒子の製造方法
WO2011162755A1 (en) * 2010-06-23 2011-12-29 Colgate-Palmolive Company Encapsulation of ingredients in lactose matrix to form active encapsulates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
CA1331713C (en) * 1988-12-29 1994-08-30 Hitoshi Iijima Granular composition for ruminant
DK0472502T3 (da) 1990-08-24 1995-10-09 Spirig Ag Fremgangsmåde til fremstilling af pellets
FI20021701L (fi) * 1991-01-30 2002-09-24 Wellcome Found Veteen dispergoituvia tabletteja
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
JP3316243B2 (ja) * 1993-01-18 2002-08-19 川鉄鉱業株式会社 粉末シリカの高分散性造粒物及びその製造方法
IT1264020B (it) 1993-01-28 1996-09-09 Recordati Chem Pharm Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
DE69632787D1 (de) 2004-07-29
WO1997010810A3 (en) 1997-06-05
US6242008B1 (en) 2001-06-05
EP0850048A2 (de) 1998-07-01
ZA967545B (en) 1998-05-12
EP0850048B1 (de) 2004-06-23
TW426525B (en) 2001-03-21
DE69632787T2 (de) 2005-08-18
CO4750645A1 (es) 1999-03-31
GB9518465D0 (en) 1995-11-08
PT850048E (pt) 2004-09-30
US6410055B1 (en) 2002-06-25
JP2000504309A (ja) 2000-04-11
US20030072809A1 (en) 2003-04-17
CY2584B2 (en) 2009-11-04
WO1997010810A2 (en) 1997-03-27
AU6889396A (en) 1997-04-09
AR004196A1 (es) 1998-11-04
ES2224175T3 (es) 2005-03-01

Similar Documents

Publication Publication Date Title
DE69525148D1 (de) Pharmazeutische formulierung
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
FI973243L (fi) Uusi farmaseuttinen yhdistelmä
NO962606L (no) Farmasöytisk sammensetning
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO981008D0 (no) Farmasöytisk formulering
BR9610817A (pt) Comprimidos mastigáveis
BR9610214A (pt) Compostos farmacéuticos
BR9600809A (pt) Medicamento
DE4294862T1 (de) Pharmazeutische Komposition
DE69614407D1 (de) Pharmazeutische zusammensetzungen
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
LV11727A (lv) Farmaceitiska kompozicija
DE69632787D1 (de) Pharmazeutische pellets
FI973280L (fi) Farmaseuttinen koostumus
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
NO965448L (no) Farmasöytiske forbindelser
DE59610423D1 (de) Partikulare arzneiform
DE19681529D2 (de) Pharmazeutische Darreichungsform
BR9605777A (pt) Composição farmacêutica
BR9605131A (pt) Composição farmacêutica
KR970008018U (ko) 장제용 위패
ATA77096A (de) Pharmazeutische präparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0850048

Country of ref document: EP